Reports

Ideas That Generate Results

Genetic Testing Market Outlook to 2017

Genetic Testing Market Outlook to 2017

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : May, 2013| No. of Pages : 140

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00  720.00
CD-ROM Mail Delivery
US$ 1300.00  780.00
Hard Copy Mail Delivery
US$ 1300.00  780.00
Electronic Access - Multi-User License
US$ 1700.00  1020.00

List of Figures:

Figure 4-1: Genetic Testing Market (Billion US$), 2012-2017
Figure 4-2: Genetic Testing Market by Geography (%), 2012
Figure 4-3: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)
Figure 4-4: Number of DTC Genetic Testing Companies by Country
Figure 6-1: Number of Laboratories and Diseases for Genetic Testing (1993-2012)
Figure 6-2: US - Number of Genetic Tests (2008 & 2012)
Figure 6-3: US - Genetic Testing Market (Billion US$), 2012-2017
Figure 6-4: Europe - Genetic Testing Market (Billion US$), 2012-2017
Figure 7-1: Global - Next Generation Sequencing Market (Billion US$), 2012-2017
Figure 7-2: Global - NGS Application by Sector (%)
Figure 7-3: Global - Next Generation Sequencing Market by Player (%), 2012
Figure 7-4: US - Non-Invasive Prenatal Diagnostics Market (Million US$), 2012-2016
Figure 7-5: US - Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 7-6: US - Personalized Cancer WGS Market (Million US$), 2012-2017
Figure 8-1: Abbott Laboratories - Revenue Breakup by Geography (%), 2012
Figure 8-2: Abbott Laboratories - Revenue Breakup by Diagnostics Division (%), 2012
Figure 8-3: Roche Holding - Diagnostic Division Revenue by Geography (%), 2012
Figure 8-4: Roche Holding - Revenue Breakup by Diagnostics Division (%), 2012
Figure 8-5: Myriad Genetics - Revenue Breakup by Business Segment (%), 2012
Figure 8-6: Life Technologies - Revenue Breakup by Geography (%), 2012
Figure 8-7: Life Technologies - Revenue Breakup by Business Segment (%), 2012
Figure 8-8: Sequenom - Revenue Breakup by Business Segment (%), 2012
Figure 8-9: Transgenomic - Revenue Breakup by Geography (%), 2012
Figure 8-10: Transgenomic - Revenue Breakup by Business Segment (%), 2012
Figure 8-11: Dako - Revenue Breakup by Geography (%), 2011
Figure 8-12: Gen-Probe, Inc. - Revenue Breakup by Geography (%), 2011
Figure 8-13: Gen-Probe, Inc. - Revenue Breakup by Business Segment (%), 2011
Figure 8-14: Quest Diagnostics - Revenue Breakup by Business Segment (%), 2012

List of Tables:

Table 4-1: Key DTC Genetic Testing Companies by Category (2011)
Table 4-2: Key Test Areas Offered in DTC Genetic Testing Segment (2011)
Table 7-1: Listed Pharmacogenomic Biomarkers in FDA Approved Cancer Therapy Labels
Table 8-1: Abbott Laboratories - Key Gene Based Product(s)
Table 8-2: Abbott Laboratories - Financial Performance (Million US$), 2010-2012
Table 8-5: Roche Molecular Diagnostics - Key Gene Based Product(s)
Table 8-6: Roche Holding - Financial Performance (Million CHF), 2010-2012
Table 8-7: Myriad Genetics - Key Gene Based Product(s)
Table 8-8: Myriad Genetics - Financial Performance (Million US$), 2010-2012
Table 8-9: Life Technologies - Key Gene Based Product(s)
Table 8-10: Life Technologies - Financial Performance (Million US$), 2010-2012
Table 8-11: Genomic Health - Key Gene Based Product(s)
Table 8-12: Genomic Health - Financial Performance (Million US$), 2010-2012
Table 8-13: Sequenom - Key Gene Based Product(s)
Table 8-14: Sequenom - Financial Performance (Million US$), 2010-2012
Table 8-15: Transgenomic - Financial Performance (Million US$), 2010-2012
Table 8-16: Dako - Key Gene Based Product(s)
Table 8-17: Dako - Financial Performance (Million DKK), 2009-2011
Table 8-18: Gen-Probe, Inc. - Key Gene Based Product(s)
Table 8-19: Gen-Probe, Inc. - Financial Performance (Million US$), 2009-2011
Table 8-20: Quest Diagnostics - Gene Based Product(s)/Service(s)
Table 8-21: Quest Diagnostics - Key Financials (Million US$), 2010-2012
Table 8-22: Genoptix - Key Gene Based Service(s)
Table 8-23: Genoptix - Financial Performance (Million US$), 2007-2009
Table 8-24: Clarient - Key Gene Based Service(s)
Table 8-25: Clarient - Financial Performance (Million US$), 2007-2009

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.